Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
M-CSF as a Marker of Bone Lesions in Multiple Myeloma
NCT02800954Completed
- Sponsor
- CHU Amiens-Picardie
- Start
- Feb 2009
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Amiens-Picardie. Primary endpoint: Serum Macrophage-Colony Stimulating Factor levels at Day 1. Started Feb 2009; status: completed.
Beyond the preview
Go deeper on NCT02800954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02800954.